Importantly, he is also visionary behind the revolutionary Regenexx® technology, a procedure which involves extracting a small bone marrow sample through a needle and a blood draw from a vein in your arm. These samples are then processed in a laboratory and the cells it contains injected into the area needing repair, with the goal of delivering large numbers of stem cells to the injured area.
Part 2 – Q&A with Dr. Chris Centeno, Visionary Behind Regenexx® Stem Cell Technology
This is Part 2 of a two-part question and answer interview with Dr. Chris Centeno, an international expert in regenerative medicine and the clinical use of mesenchymal stem cells (MSCs) for orthopedic applications. He specializes in clinical use of adult stem cells for orthopedic injuries, which he treats through same-day procedures at his clinic in Denver, Colorado, and through cultured expansion of mesenchymal stem cells at a clinic in Grand Cayman. He first performed these adult stem cell procedures in the U.S. in 2005-2006, and his clinic has since has treated thousands orthopedic patients with stem cell based therapies.
As the President/CEO of a stem cell research firm and an international rugby athlete, I have both professional and personal interest in the technologies that he has developed. He is best known for the Regenexx® technology, an approach that uses needle based procedures coupled with sophisticated guidance techniques to place large numbers of stem cells at the site needing repair. This approach can often replace the need for invasive orthopedic surgeries.
Read Part 1 of the interview here.
Part 2 – Q&A with Dr. Chris Centeno, International Expert in Use of MSCs for Orthopedic Applications
Cade Hildreth: The Regenexx® procedure works very well for anterior cruciate ligament (ACL) tears that have an inch or less of retraction. How will this treatment option affect the hundreds of thousands of ACL surgeries that are currently done each year?